Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2005-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BBRC.2005.01.109PMID 15721277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influenza and pneumococcal immunization in diabetes.

  2004cited by this paper
• Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota.

  2001cited by this paper
• Use of influenza and pneumococcal vaccines in people with diabetes.

  2000cited by this paper
• Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein.

  1999cited by this paper
• Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults.

  1999cited by this paper
• Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study.

  1998cited by this paper
• Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza.

  1998cited by this paper
• Hepatitis B Vaccination in Diabetic Patients: Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen

  1997cited by this paper
• Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes

  1997cited by this paper
• Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996).

  1997cited by this paper
• Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly

  1996cited by this paper
• The effectiveness of vaccination against influenza in healthy, working adults.

  1995cited by this paper
• Influenza immunization policies in Europe and the United States.

  1995cited by this paper
• Reduced immune response to hepatitis B vaccine in children with insulin dependent diabetes

  1995cited by this paper
• Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination?

  1995cited by this paper
• Low Mumps Antibody Levels Induced by Mumps‐Measles‐Rubella Vaccinations in Type 1 Diabetic Children

  1994cited by this paper
• A prospective study of in vitro anti‐HBs producing B cells (spot‐ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls

  1991cited by this paper
• Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands.

  1991cited by this paper
• Influenza Infection and Diabetes Mellitus: Case for Annual Vaccination

  1990cited by this paper
• Immune responses to killed influenza vaccine in patients with type 1 diabetes: altered responses associated with HLA-DR 3 and DR 4.

  1988cited by this paper
• Nonenzymatic Glycosylation of Serum IgG and Its Effect on Antibody Activity in Patients With Diabetes Mellitus

  1987cited by this paper
• Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus

  1987cited by this paper
• Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus

  1987cited by this paper
• The immune response to influenza vaccination in diabetic patients

  1986cited by this paper
• Acquired defect in interleukin-2 production in patients with type I diabetes mellitus.

  1986cited by this paper
• Anti-islet Cellular and Humoral Immunity, T-Cell Subsets, and Thymic Function in Type I Diabetes

  1985cited by this paper
• Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena

  1984cited by this paper
• The Influence of Genetic Background on the Susceptibility of Inbred Mice to Streptozotocin-induced Diabetes

  1984cited by this paper
• Phagocytotic Activity of Monocytes from Diabetic Patients

  1983cited by this paper
• Influenza Immunization in Adults with Diabetes Mellitus

  1983cited by this paper
• Induction of Insulin-dependent Diabetes by Streptozotocin Inhibition by Estrogens and Potentiation by Androgens

  1982cited by this paper
• Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics.

  1980cited by this paper
• Androgen Sensitization of Streptozotocin-induced Diabetes in Mice

  1980cited by this paper
• Immune and autoimmune aspects of diabetes mellitus.

  1980cited by this paper
• Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.

  1980cited by this paper
• Sex differences in the multiple-dose streptozotocin model of diabetes.

  1978cited by this paper

• Insulin deficiency inhibits vaccine-mediated antibody and germinal center B-cell formation in mice

  2025cites this paper
• Respiratory Tract Infections in Diabetes – Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity

  2022cites this paper
• Type I Diabetes Mellitus Increases the Cardiovascular Complications of Influenza Virus Infection

  2021cites this paper
• Immunization with DNA prime-subunit protein boost strategy based on influenza H9N2 virus conserved matrix protein M1 and its epitope screening

  2020cites this paper
• A review of COVID‐19 vaccines and major considerations for diabetic patients

  2020cites this paper
• Influenza in High-Risk Hosts-Lessons Learned from Animal Models.

  2019cites this paper
• Rapid detection and clinical spectrum of the novel influenza H1N1 strain in a diabetic pediatric population

  2019cites this paper
• Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?

  2017cites this paper
• Mice with type 1 diabetes exhibit increased susceptibility to influenza A virus.

  2017cites this paper
• Benefits of flu vaccination for persons with diabetes mellitus: A review.

  2017cites this paper
• Bias in the measure of the effectiveness of seasonal influenza vaccination among diabetics.

  2016cites this paper
• Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model

  2016cites this paper
• Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant

  2015cites this paper
• Long-Term Immunogenicity of an Inactivated Split-Virion 2009 Pandemic Influenza A H1N1 Virus Vaccine with or without Aluminum Adjuvant in Mice

  2015cites this paper
• Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice

  2011influential citation
• The humoral immune response to the inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with Type 2 diabetes mellitus in Korea

  2011cites this paper
• Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.

  2010cites this paper
• A DNA Vaccine-Encoded Nucleoprotein of Influenza Virus Fails To Induce Cellular Immune Responses in a Diabetic Mouse Model

  2010cites this paper
• Comparison of Adjuvant Efficacy of Chitosan and Aluminum Hydroxide for Intraperitoneally Administered Inactivated Influenza H5N1 Vaccine

  2010cites this paper
• Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein

  2010cites this paper
• Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.

  2006cites this paper
• Maternal Immunization with Both Hemagglutinin- and Neuraminidase-Expressing DNAs Provides an Enhanced Protection Against a Lethal Influenza Virus Challenge in Infant and Adult Mice

  2005cites this paper
• Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.

  2005cites this paper